Fig. 2
From: Safety profile of faricimab: a multi-source pharmacovigilance analysis using FAERS and JADER
The number of AEs reported by FAERS and JADER yearly
Fig. 2 | BMC Pharmacology and Toxicology
From: Safety profile of faricimab: a multi-source pharmacovigilance analysis using FAERS and JADER
The number of AEs reported by FAERS and JADER yearly